Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban - Steiner, Thorsten; Böhm, M.; Dichgans, M.; Diener, H.-C.; Ell, C.; Endres, M.; Epple, C.; Grond, M.; Laufs, U.; Nickenig, G.; Riess, H.; Röther, J.; et al. (Clinical research in cardiology, 2013)
Published online: 14 May 2013